Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells
- 14 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 18 (6), 1024-1035
- https://doi.org/10.1038/cdd.2010.175
Abstract
In addition to act as an antiapoptotic protein, B-cell lymphoma (bcl)-2 can also promote tumor angiogenesis. In this context, we have previously demonstrated that under hypoxia bcl-2 promotes hypoxia-inducible factor-1 (HIF-1)-mediated vascular endothelial growth factor (VEGF) expression in melanoma and breast carcinoma. Here, we report on the role of the BH4 domain in bcl-2 functions, by showing that removal of or mutations at the BH4 domain abrogate the ability of bcl-2 to induce VEGF protein expression and transcriptional activity under hypoxia in human melanoma cells. We have also extended this observation to other human tumor histotypes, such as colon, ovarian and lung carcinomas. The involvement of BH4 on HIF-1α protein expression, stability, ubiquitination and HIF-1 transcriptional activity was also demonstrated in melanoma experimental model. Moreover, we validated the role of the BH4 domain of bcl-2 in the regulation of HIF-1/VEGF axis, demonstrating that BH4 peptide is sufficient to increase HIF-1α protein half-life impairing HIF-1α protein ubiquitination, and to enhance VEGF secretion in melanoma cells exposed to hypoxia. Finally, we found that the mechanism by which bcl-2 regulates HIF-1-mediated VEGF expression does not require BH1 and BH2 domains, and it is independent of antiapoptotic and prosurvival function of bcl-2.Keywords
This publication has 36 references indexed in Scilit:
- Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activityOncogene, 2003
- Deletion of the BH1 Domain of Bcl-2 Accelerates Apoptosis by Acting in a Dominant Negative FashionJournal of Biological Chemistry, 2003
- Bcl-2, via Its BH4 Domain, Blocks Apoptotic Signaling Mediated by Mitochondrial RasJournal of Biological Chemistry, 2003
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002
- Bcl‐2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF‐1mediated transcriptional activityThe FASEB Journal, 2002
- Angiogenic Potential of Prostate Carcinoma Cells Overexpressing bcl-2JNCI Journal of the National Cancer Institute, 2001
- Interferon-? sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosisJournal of Cellular Physiology, 2000
- Bcl‐2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression andin vivoangiogenesis in a breast carcinoma lineThe FASEB Journal, 2000
- BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell deathProceedings of the National Academy of Sciences, 2000
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990